Niki BioSolutions, Inc. Cash and Restricted Cash
Niki BioSolutions, Inc. (NIKI) had Cash and Restricted Cash of $3.45 million as of 2025-12-31, per its S-4/A filed 2026-05-11.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-05-11
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.45M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.27M.
- 2025-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.76M.
- 2024-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $874.24K.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2025-12-31 | $3.45M S-4/A · filed 2026-05-11 |
| 2025-09-30 | $2.27M 6-K · filed 2026-01-22 |
| 2025-06-30 | $2.76M 6-K · filed 2025-10-08 |
| 2024-12-31 | $874.24K S-4/A · filed 2026-05-11 |
| 2024-09-30 | $754.59K 6-K · filed 2026-01-22 |
| 2024-06-30 | $783.09K 6-K · filed 2025-10-08 |
| 2023-12-31 | $2.01M S-4/A · filed 2026-05-11 |
| 2023-06-30 | $470.64K 6-K · filed 2024-12-20 |
| 2022-12-31 | $5.01M S-4/A · filed 2026-05-11 |
| 2022-06-30 | $7.20M 6-K · filed 2023-12-22 |
| 2021-12-31 | $8.26M 6-K · filed 2025-10-08 |
| 2021-06-30 | $20.07M 6-K · filed 2022-09-30 |
| 2020-12-31 | $3.63M 20-F · filed 2024-04-30 |
| 2020-06-30 | $4.12M 6-K · filed 2021-09-15 |
| 2019-12-31 | $5.29M 20-F · filed 2023-04-28 |
| 2019-06-30 | $4.47M 6-K · filed 2020-09-02 |
| 2018-12-31 | $26.11M 20-F/A · filed 2023-01-17 |
| 2017-12-31 | $16.73M 20-F · filed 2021-04-19 |
| 2017-02-28 | $623.78K 20-F · filed 2020-04-29 |